Literature DB >> 17851733

Non-transferrin-bound iron in plasma following administration of oral iron drugs.

Bernd Dresow1, Doerte Petersen, Roland Fischer, Peter Nielsen.   

Abstract

Non-transferrin-bound iron (NTBI) was detected in serum samples from volunteers with normal iron stores or from patients with iron deficiency anaemia after oral application of pharmaceutical iron preparations. Following a 100 mg ferrous iron dosage, NTBI values up to 9 muM were found within the time period of 1-4 h after administration whereas transferrin saturation was clearly below 100%. Smaller iron dosages (10 and 30 mg) gave lower but still measurable NTBI values. The physiological relevance of this finding for patients under iron medication has to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17851733     DOI: 10.1007/s10534-007-9116-5

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  20 in total

1.  Safety and efficacy of sucrosomial iron in inflammatory bowel disease patients with iron deficiency anemia.

Authors:  Gianluca Abbati; Federica Incerti; Chiara Boarini; Francesca Pileri; Davide Bocchi; Paolo Ventura; Elena Buzzetti; Antonello Pietrangelo
Journal:  Intern Emerg Med       Date:  2018-11-29       Impact factor: 3.397

2.  Association of oral iron supplementation with birth outcomes in non-anaemic South Indian pregnant women.

Authors:  L Shastri; P E Mishra; P Dwarkanath; T Thomas; C Duggan; R Bosch; C M McDonald; A Thomas; A V Kurpad
Journal:  Eur J Clin Nutr       Date:  2014-11-19       Impact factor: 4.016

3.  Safety and efficacy of iron supplements in malaria-endemic areas.

Authors:  Richard F Hurrell
Journal:  Ann Nutr Metab       Date:  2011-11-25       Impact factor: 3.374

4.  Transport of Non-Transferrin Bound Iron to the Brain: Implications for Alzheimer's Disease.

Authors:  Ajai K Tripathi; Shilpita Karmakar; Abhishek Asthana; Ajay Ashok; Vilok Desai; Shounak Baksi; Neena Singh
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron.

Authors:  Eldad A Hod; Gary M Brittenham; Genia B Billote; Richard O Francis; Yelena Z Ginzburg; Jeanne E Hendrickson; Jeffrey Jhang; Joseph Schwartz; Shruti Sharma; Sujit Sheth; Anthony N Sireci; Hannah L Stephens; Brie A Stotler; Boguslaw S Wojczyk; James C Zimring; Steven L Spitalnik
Journal:  Blood       Date:  2011-10-20       Impact factor: 22.113

Review 6.  Safety of iron fortification and supplementation in malaria-endemic areas.

Authors:  Gary M Brittenham
Journal:  Nestle Nutr Inst Workshop Ser       Date:  2012

7.  Circulating non-transferrin-bound iron after oral administration of supplemental and fortification doses of iron to healthy women: a randomized study.

Authors:  Gary M Brittenham; Maria Andersson; Ines Egli; Jasmin Tajeri Foman; Christophe Zeder; Mark E Westerman; Richard F Hurrell
Journal:  Am J Clin Nutr       Date:  2014-07-23       Impact factor: 7.045

8.  Iron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel disease.

Authors:  Miranda C E Lomer; William B Cook; Hamid Jan B Jan-Mohamed; Carol Hutchinson; Ding Yong Liu; Robert C Hider; Jonathan J Powell
Journal:  Br J Nutr       Date:  2011-12-09       Impact factor: 3.718

9.  Efficacy, Tolerability, and Acceptability of Iron Hydroxide Polymaltose Complex versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients with Iron Deficiency Anemia.

Authors:  Beril Yasa; Leyla Agaoglu; Emin Unuvar
Journal:  Int J Pediatr       Date:  2011-10-31

10.  Effect of supplementation with zinc and other micronutrients on malaria in Tanzanian children: a randomised trial.

Authors:  Jacobien Veenemans; Paul Milligan; Andrew M Prentice; Laura R A Schouten; Nienke Inja; Aafke C van der Heijden; Linsey C C de Boer; Esther J S Jansen; Anna E Koopmans; Wendy T M Enthoven; Rob J Kraaijenhagen; Ayse Y Demir; Donald R A Uges; Erasto V Mbugi; Huub F J Savelkoul; Hans Verhoef
Journal:  PLoS Med       Date:  2011-11-22       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.